Trademark: 97251008
Word
PECSA
Status
Pending
Status Code
661
Status Date
Wednesday, November 15, 2023
Serial Number
97251008
Mark Type
4000
Filing Date
Wednesday, February 2, 2022

Trademark Owner History

Classifications
5 Medicinal drinks; Medicinal herb extracts; Medicinal herbal extracts for medical purposes; Medicinal herbal preparations; Medicinal herbs; Medicinal herbs in dried or preserved form; Medicinal oils; Medicinal tea; Anti-inflammatory preparations; Beverages containing cannabis extract, cannabigerol, cannabigerolic acid; Decoctions of medicinal herb; Dietary supplement beverage for treatment of neurological diseases, seizures, inflammation, viral infection, diabetes, metabolic disorders, free radical excess; Dietary supplements also containing cannabis oil; full spectrum cannabis extract in the naturure of concentrated components of cannabis plant for medical purposes; Dietary supplements consisting primarily of cannabis oil; Dietary supplements for human beings and animals; Dietary supplements for human consumption; Dietary supplements for pets; Dietary supplements for treatment of insomnia, sleep disorders, depression, anxiety, neurodegenerative diseases, Alzheimer's disease, dementia, Parkinson's disease, post traumatic stress disorder., phobias, addictions, attention deficit hyperactivity disorder, autism, mood disorders, brain disorders, central nervous system disorders; Dietary supplements in the form of cannabis extract oil for medical purposes; Dietary and nutritional supplements containing panakeia extract in the nature of powder, oil or solution for medical purposes; Dietary beverage supplements for human consumption in liquid and dry mix form for therapeutic purposes; Dietary fiber for treating constipation; Dietary fiber for use as an ingredient in the manufacture of dietary supplements; Dietary food supplements; Dietary supplements; Dietary supplements for humans; Food supplements for treatment of neurological diseases, seizures, inflammation, viral infection, diabetes, metabolic disorders, free radical excess; Health food supplements; Herb tea for medicinal purposes; Herbal extracts for medical purposes; Herbal supplements; Herbal tea for medicinal purposes; Liquid herbal supplements; Liquid nutritional supplement; Medicinal roots; Natural herbal supplements; Nutraceuticals for use as a dietary supplement; Nutraceuticals for use as a dietary supplement for treatment of insomnia, sleep disorders, depression, anxiety, neurodegenerative diseases, Alzheimer's disease, dementia, Parkinson's disease, post traumatic stress disorder, phobias, addictions, attention deficit hyperactivity disorder, autism, mood disorders, brain disorders, central nervous system disorders; treatment of neurological diseases, seizures, inflammation, viral infection, diabetes, metabolic disorders, free radical excess; Nutritional supplements; Nutritional supplements consisting primarily of cannabis oil; Nutritional supplements for treatment of neurological diseases, seizures, inflammation, viral infection, diabetes, metabolic disorders, free radical excess; Nutritional supplements for treatment of insomnia, sleep disorders, depression, anxiety, neurodegenerative diseases, Alzheimer's disease, dementia, Parkinson's disease, post traumatic stress disorder., phobias, addictions, attention deficit hyperactivity disorder, autism, mood disorders, brain disorders, central nervous system disorders; Nutritional supplements in the form of oil, ground seeds, capsules, gelcaps in the nature of distary supplemnts for humans; Nutritional food additives for medical purposes in the nature of natural food extracts derived from cannabis; Plant and herb extracts for medicinal purposes; Plant and herb extracts sold as components of medicated cosmetics; Plant extracts for medical, veterinary and pharmaceutical purposes; Plant extracts for pharmaceutical purposes, none of the foregoing containing cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of more than 0.3 percent on a dry weight basis

Trademark Events
Nov 15, 2023
Teas/Email Correspondence Entered
Nov 14, 2023
Correspondence Received In Law Office
Nov 14, 2023
Teas Response To Office Action Received
Aug 14, 2023
Notification Of Non-Final Action E-Mailed
Aug 14, 2023
Non-Final Action E-Mailed
Aug 14, 2023
Non-Final Action Written
Jul 17, 2023
Assigned To Examiner
Feb 8, 2022
New Application Office Supplied Data Entered
Feb 5, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24